This article updates the Heart Failure Association of the European Society of Cardiology
(ESC) 2007 classification of advanced heart failure and describes new diagnostic and …

Heart transplantation continues to be limited by a paucity of donor organs despite
innovations in organ procurement and organ preservation, greater willingness to accept …

The field of heart transplantation continues to evolve, with major changes in allocation
systems and the increasing use of extended-criteria donor hearts, including hearts from …

Heart transplantation is the only cure for patients with terminal cardiac failure, but the supply
of allogeneic donor organs falls far short of the clinical need 1, 2, 3. Xenotransplantation of …

Endomyocardial biopsy (EMB) screening represents the standard of care for detecting
allograft rejections after heart transplant. Manual interpretation of EMBs is affected by …

The past year has been notable for the multiple celebrations and symposia around the globe
commemorating the first heart transplant ever performed by Dr. Christiaan Barnard at Groote …

This 34th Adult Lung and Heart-Lung Transplant Report summarizes data from 60,107 adult
lung and 3,992 adult heart-lung transplants performed through June 30, 2016, and reported …

Dilated cardiomyopathy (DCM) is characterized by left ventricular dilatation and,
consecutively, contractile dysfunction. The causes of DCM are heterogeneous. DCM often …

Standardized donor-derived cell-free DNA (dd-cfDNA) testing has been introduced into
clinical use to monitor kidney transplant recipients for rejection. This report describes the …

Heart transplantation has become a standard therapy option for advanced heart failure. The
translation of heart transplantation from innovative experiments to long-term clinical success …